Mammography no more sensitive in women with family history of breast cancer, says UCSF/SFVAMC study

December 03, 2000

Mammography is no more sensitive at detecting breast cancer in women with a family history of the disease than in women without it, according to a new study by University of California, San Francisco and San Francisco Veterans Affairs Medical Center researchers and their colleagues.

The new findings call into question a recommendation included in most screening guidelines - that women whose immediate relatives have had the disease should be screened at a younger age than women without such a family history.

All guidelines for mammography screening recommend it for women between ages 50 and 69 (some guidelines, especially in the US, recommend screening should begin at age 40). Most also recommend earlier screening for women whose mother, sister or daughter had the disease, said Karla Kerlikowske, MD, chief of the Women Veterans Comprehensive Health Center at the SFVAMC and UCSF assistant professor of medicine and epidemiology and biostatistics. Women with such a family history are nearly twice as likely to get breast cancer in their lifetimes.

"People have thought that because women with a family history are at higher risk than women of a similar age without a family history, maybe mammography would perform better in these women. But there's no data to support that hypothesis," she said.

The study by Kerlikowske and her colleagues, which is published in the latest issue of the Annals of Internal Medicine, assessed the accuracy of mammography by analyzing data from more than 389,000 women in seven mammography registries.

They found that mammography it missed a similar percentage of cancers whether women had a family history or not. "We hypothesized that the chance that mammography misses a cancer case would be lower in these women at higher risk, but it's not. The sensitivity of mammography is primarily influenced by the age of the woman, and is not affected by family history ," she said.

Previous studies have shown that mammography is more sensitive at detecting cancer in older women. Kerlikowske's new study confirms that mammography detects nearly 85 percent of cancer cases in women ages 50 to 69, but only about 75 percent of cases for women 30 to 49.

The study also showed that mammography found more cases of breast cancer among the women with a family history, an expected result given that breast cancer is more common in these women. Mammography detected six cases per 1000 women with a family history, versus four cases per 1000 women without a family history.

Detecting a few more cases of cancer might sound like a good reason to recommend mammography at an earlier age for women with a family history, but Kerlikowske argues that the justification for such a recommendation should not be based simply on detecting more cancers, but on whether the benefits of the test outweigh the harms.

The overall benefit of screening women under 50 is comparatively small, Kerlikowske said. To prevent one breast cancer death among women 40 to 49 years of age, 2500 women would have to be regularly screened, whereas only 270 women in the 50- to 69-year old group need to be regularly screened to prevent one breast cancer death.

Since mammography is no more sensitive in women with a family history, recommending earlier screening for these women would subject thousands of younger women to the test for a very small benefit, Kerlikowske said.

The risks of mammography include the extra testing and anxiety that accompany a positive result, which in a great majority of cases turns out to be a false positive (the test suggested cancer where none existed). The new study found that women with a family history of breast cancer had a greater chance of a false-positive result.

Kerlikowske said she hopes this study will convince some doctors to consider their decision more carefully before automatically advising mammography at an earlier age for women with a family history, and to inform women of the potential benefits and harms of screening. Co-investigators on this study included Virginia Ernster, PhD, UCSF vice chair and professor of epidemiology and biostatistics; and researchers at seven other universities and institutions.
The study was supported by grants from the National Cancer Institute and the Department of Defense.

University of California - San Francisco

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to